Table 3.

Associations Between ART Deferral, CD4⁺ T-Cell Count, and Key-at-Risk Population Among ART-Prescribing Physicians (N = 214) in Malaysia (June–December 2013)

Characteristic	Key-at-Risk Population*			Clinical Scenario
		CD4 ≤50 (CD4 = 17) AIDS-Defining Condition		CD4 ≤200 (CD4 = 176) AIDS-Defining Condition		CD4 ≤350 (CD4 = 305) 2010 Guidelines		CD4 ≤500 (CD4 = 470) 2013 Guidelines
		AOR (95% CI)	P Value	AOR (95% CI)	P Value	AOR (95% CI)	P Value	AOR (95% CI)	P Value
Substance use	Injects or uses drugs	18.9 (9.8–36.5)	<.0001	14.5 (8.6– 24.6)	<.0001	6.9 (4.8– 9.9)	<.0001	2.0 (1.4– 2.7)	<.0001
	Consumes alcohol	16.5 (8.3– 33.1)	<.0001	11.4 (6.7– 19.5)	<.0001	5.9 (4.2– 8.3)	<.0001	3.4 (2.3– 5.1)	<.0001
	Currently receives MMT	2.9 (1.5– 5.7)	.0022	1.9 (1.2– 2.9)	.0020	2.0 (1.5– 2.5)	<.0001	1.6 (1.3– 2.1)	<.0001
Social situation	Recently released from prison	12.3 (6.3– 24.1)	<.0001	8.4 (5.0– 14.0)	<.0001	5.1 (3.6– 7.1)	<.0001	2.6 (1.9– 3.7)	<.0001
	Lives alone and not with family	8.3 (4.3– 16.0)	<.0001	5.5 (3.3– 9.1)	<.0001	3.5 (2.5– 4.7)	<.0001	2.2 (1.6– 3.1)	<.0001
	Has HIV-uninfected partner	1.4 (0.7– 2.6)	.3666	0.79 (0.5– 1.1)	.257	0.81 (0.63– 1.0)	.132	0.43 (0.34– 0.57)	<.0001
Sexual minority	Commercial sex worker	3.0 (1.6– 5.8)	.0008	1.8 (1.1– 2.8)	.008	1.1 (0.84–1.5)	.414	0.55 (0.44–0.70)	<.0001
	Man who has sex with men	1.6 (0.9– 2.9)	.1331	1.2 (0.76–1.9)	.405	1.0 (0.79–1.2)	1.000	0.80 (0.66–0.98)	.037
	Transgender person	2.2 (1.2– 4.2)	.0135	1.2 (0.84–2.0)	.248	1.3 (1.1– 1.6)	.004	1.1 (0.50–1.3)	.0247

Abbreviations: AIDS, acquired immune deficiency syndrome; ART, antiretroviral therapy; AOR, adjusted odds ratio; CI, confidence interval; MMT, methadone maintenance therapy.

*Compared with a person who acquired HIV from a main sexual partner; Bonferroni-corrected P value = .0014.